What is the gold standard test for diagnosing insulinoma?
**Core Concept**
The diagnosis of insulinoma, a type of pancreatic tumor that produces excess insulin, relies on demonstrating inappropriate insulin secretion in the context of hypoglycemia. **Insulinomas** are usually benign but can cause significant morbidity due to excessive insulin production. The diagnostic approach involves a combination of clinical presentation, laboratory tests, and sometimes imaging.
**Why the Correct Answer is Right**
The correct answer involves a specific test that directly measures insulin levels in the context of hypoglycemia, which is crucial for diagnosing insulinoma. This test is the **72-hour fast test**, which monitors the patient's blood glucose, insulin, proinsulin, and C-peptide levels during a prolonged fast. This test can demonstrate inappropriate insulin secretion even when the patient is hypoglycemic.
**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because while imaging tests like CT or MRI can help locate the tumor once the diagnosis of insulinoma is suspected, they are not the gold standard for diagnosis.
**Option B:** Is incorrect because it does not directly relate to the diagnostic process for insulinoma.
**Option C:** Is incorrect as it is not specified, but typically, other tests like the glucose tolerance test are not the primary method for diagnosing insulinoma.
**Option D:** Is incorrect because, similar to Option A, it might be involved in the diagnostic process but is not the gold standard.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **insulinomas** produce both insulin and its precursor, proinsulin, which can be measured during the diagnostic fast. The presence of hypoglycemia with elevated insulin and C-peptide levels is pathognomonic for insulinoma.
**Correct Answer:** D. 72-hour fast test.